Not only did we validate the previously reported common NKTCL mutational targets such as STAT3, TP53, and DDX3X [7, 8, 39], we also identified a list of novel mutational targets and mutational types across both nucleotide and structure levels. This evidence concerns the gene STAT3 and extranodal nasal NK/T cell lymphoma.